110 related articles for article (PubMed ID: 29961136)
1. Levothyroxine use and the risk of breast cancer: a nation-wide population-based case-control study.
Wu CC; Yu YY; Yang HC; Nguyen PA; Poly TN; Islam MM; Iqbal U; Khan HAA; Wang YC; Cheng YT; Li YC; Jian WS
Arch Gynecol Obstet; 2018 Aug; 298(2):389-396. PubMed ID: 29961136
[TBL] [Abstract][Full Text] [Related]
2. Risk of cancer in long-term levothyroxine users: Retrospective population-based study.
Wu CC; Islam MM; Nguyen PA; Poly TN; Wang CH; Iqbal U; Li YJ; Yang HC
Cancer Sci; 2021 Jun; 112(6):2533-2541. PubMed ID: 33793038
[TBL] [Abstract][Full Text] [Related]
3. Levothyroxine treatment and occurrence of fracture of the hip.
Sheppard MC; Holder R; Franklyn JA
Arch Intern Med; 2002 Feb; 162(3):338-43. PubMed ID: 11822927
[TBL] [Abstract][Full Text] [Related]
4. Risk of osteoporosis in thyroid cancer patients using levothyroxine: a population-based study.
Lin SY; Lin CL; Chen HT; Kao CH
Curr Med Res Opin; 2018 May; 34(5):805-812. PubMed ID: 28884595
[TBL] [Abstract][Full Text] [Related]
5. Statin use and the risk of breast cancer: a population-based case-control study.
Chan TF; Wu CH; Lin CL; Yang CY
Expert Opin Drug Saf; 2014 Mar; 13(3):287-93. PubMed ID: 24490820
[TBL] [Abstract][Full Text] [Related]
6. J-Shaped Association Between Postoperative Levothyroxine Dosage and Fracture Risk in Thyroid Cancer Patients: A Retrospective Cohort Study.
Shin DW; Suh B; Lim H; Yun JM; Song SO; Park Y
J Bone Miner Res; 2018 Jun; 33(6):1037-1043. PubMed ID: 29447437
[TBL] [Abstract][Full Text] [Related]
7. Oral contraceptives and breast cancer risk in Taiwan, a country of low incidence of breast cancer and low use of oral contraceptives.
Chie WC; Li CY; Huang CS; Chang KJ; Yen ML; Lin RS
Int J Cancer; 1998 Jul; 77(2):219-23. PubMed ID: 9650556
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer among young U.S. women in relation to oral contraceptive use.
White E; Malone KE; Weiss NS; Daling JR
J Natl Cancer Inst; 1994 Apr; 86(7):505-14. PubMed ID: 8133534
[TBL] [Abstract][Full Text] [Related]
9. Statin use and the risk of female lung cancer: a population-based case-control study.
Cheng MH; Chiu HF; Ho SC; Yang CY
Lung Cancer; 2012 Mar; 75(3):275-9. PubMed ID: 21958449
[TBL] [Abstract][Full Text] [Related]
10. Falling threshold for treatment of borderline elevated thyrotropin levels-balancing benefits and risks: evidence from a large community-based study.
Taylor PN; Iqbal A; Minassian C; Sayers A; Draman MS; Greenwood R; Hamilton W; Okosieme O; Panicker V; Thomas SL; Dayan C
JAMA Intern Med; 2014 Jan; 174(1):32-9. PubMed ID: 24100714
[TBL] [Abstract][Full Text] [Related]
11. Levothyroxine treatment is associated with an increased relative risk of overall and organ specific incident cancers - a cohort study of the Swedish population.
Wändell P; Carlsson AC; Li X; Sundquist J; Sundquist K
Cancer Epidemiol; 2020 Jun; 66():101707. PubMed ID: 32222650
[TBL] [Abstract][Full Text] [Related]
12. Relationships between critical period of estrogen exposure and circulating levels of insulin-like growth factor-I (IGF-I) in breast cancer: evidence from a case-control study.
Wu MH; Chou YC; Chou WY; Hsu GC; Chu CH; Yu CP; Yu JC; Sun CA
Int J Cancer; 2010 Jan; 126(2):508-14. PubMed ID: 19585556
[TBL] [Abstract][Full Text] [Related]
13. Statins are associated with a reduced risk of gastric cancer: a population-based case-control study.
Chiu HF; Ho SC; Chang CC; Wu TN; Yang CY
Am J Gastroenterol; 2011 Dec; 106(12):2098-103. PubMed ID: 21844922
[TBL] [Abstract][Full Text] [Related]
14. Statin use and the risk of pancreatic cancer: a population-based case-control study.
Chiu HF; Chang CC; Ho SC; Wu TN; Yang CY
Pancreas; 2011 Jul; 40(5):669-72. PubMed ID: 21654539
[TBL] [Abstract][Full Text] [Related]
15. Statin use and the risk of esophageal cancer: a population-based case-control study.
Chan TF; Chiu HF; Wu CH; Lin CL; Yang CY
Expert Opin Drug Saf; 2013 May; 12(3):293-8. PubMed ID: 23470154
[TBL] [Abstract][Full Text] [Related]
16. Antihypertensive agents and the risk of breast cancer in women aged 55 years and older: a nested case-control study.
Chang CH; Chiang CH; Yen CJ; Wu LC; Lin JW; Lai MS
J Hypertens; 2016 Mar; 34(3):558-66; discussion 566. PubMed ID: 26818924
[TBL] [Abstract][Full Text] [Related]
17. Household and occupational exposure to pesticides and risk of breast cancer.
El-Zaemey S; Heyworth J; Glass DC; Peters S; Fritschi L
Int J Environ Health Res; 2014 Apr; 24(2):91-102. PubMed ID: 23767826
[TBL] [Abstract][Full Text] [Related]
18. Oral contraceptive use and other risk factors in relation to HER-2/neu overexpression in breast cancer among young women.
Gammon MD; Hibshoosh H; Terry MB; Bose S; Schoenberg JB; Brinton LA; Bernstein JL; Thompson WD
Cancer Epidemiol Biomarkers Prev; 1999 May; 8(5):413-9. PubMed ID: 10350436
[TBL] [Abstract][Full Text] [Related]
19. A case-control study of levothyroxine and the risk of colorectal cancer.
Rennert G; Rennert HS; Pinchev M; Gruber SB
J Natl Cancer Inst; 2010 Apr; 102(8):568-72. PubMed ID: 20305129
[TBL] [Abstract][Full Text] [Related]
20. Tamoxifen usage correlates with increased risk of Parkinson's disease in older women with breast cancer: a case-control study in Taiwan.
Lin HF; Liao KF; Chang CM; Lin CL; Lai SW
Eur J Clin Pharmacol; 2018 Jan; 74(1):99-107. PubMed ID: 28967041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
